Cellectar Biosciences
CLRB
CLRB
1.30
USD
-0.09
6.47%
At close
Updated
Oct 14, 1:59 PM EDT
Pre-market
After hours
1 day
-6.47%
5 days
-17.2%
1 month
-43.72%
3 months
-50.57%
6 months
-55.93%
Year to date
-62.54%
1 year
-73.84%
5 years
-99.52%
10 years
-99.98%
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
AWMDMG
1
Austin W. Marxe & David M. Greenhouse
New York
| $3.3M | +$6.39M | +74 | New |
|
| 2 |
SM
2
Sabby Management
Miami Beach,
Florida
| $1.66M | +$2.07M | +24 | New |
|
| 3 |
CAM
3
Cormorant Asset Management
Boston,
Massachusetts
| $1.18M | +$1.55M | +18 | New |
|
| 4 |
SC
4
Sophrosyne Capital
New York
| $389K | +$518K | +6 | New |
|
| 5 |
5
Fidelity Investments
Boston,
Massachusetts
| $224K | +$259K | +3 | New |
|
| 6 |
BA
6
Bard Associates
Chicago,
Illinois
| $95K | +$86.3K | +1 | New |
|
| 7 |
KCM
7
Knoll Capital Management
Miami,
Florida
| $33K | – | – | – |
|
| 8 |
8
Morgan Stanley
New York
| $6K | – | – | – |
|
| 9 |
U
9
UBS
Zurich,
Switzerland
| $6K | – | – | – |
|